This is thought-provoking. Perhaps a little industry-biased?!
Should Congress Allow FDA To Give Reversible Drug Approvals? - Forbes:
"Should the Food and Drug Administration be able to give drug approvals more often, then yank them if later data don’t bear out the benefits? Forbes contributor Avik Roy made exactly that argument in a recent paper for the Manhattan Institute, an industry-funded, conservative think tank where he is a senior fellow. Roy is also an adviser to the Romney campaign on health care."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - GMP and QSR Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store
Saturday, May 12, 2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment